{"id":"W3139210094","doi":"10.1016/s2665-9913(21)00010-2","title":"Safety and efficacy of tofacitinib up to 48 months in patients with active psoriatic arthritis: final analysis of the OPAL Balance long-term extension study","year":2021,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Pfizer (Canada); Toronto Western Hospital","funders":"National Institute for Health and Care Research; Catholic Medical Center; Pfizer","keywords":"Tofacitinib; Medicine; Psoriatic arthritis; Tolerability; Adverse effect; Placebo; Janus kinase inhibitor; Internal medicine; Methotrexate; Psoriasis; Incidence (geometry); Arthritis; Surgery; Rheumatoid arthritis; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001112791,0.0001319353,0.001037046,0.00007318504,0.00006831896,0.000003629477,0.00008974842,0.0000371596,0.00003754436],"category_scores_gemma":[0.0001824957,0.00007450258,0.00006604755,0.0005755142,0.0001230831,0.0000219394,0.0001280025,0.0001148311,0.000001403111],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002530294,"about_ca_system_score_gemma":0.00003701607,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001809568,"about_ca_topic_score_gemma":0.00192737,"domain_scores_codex":[0.9988364,0.0001574342,0.0003395391,0.0002551265,0.0002007479,0.0002107525],"domain_scores_gemma":[0.9990342,0.0001726108,0.0001656717,0.0004523373,0.0001395287,0.0000357083],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003537578,0.0005931425,0.9799926,0.00002425837,0.001127819,0.00003595056,0.002590136,0.00001857828,0.000006900474,0.0000517975,0.00001221953,0.01200907],"study_design_scores_gemma":[0.01627385,0.0004818985,0.9815936,0.0003342078,0.0004938365,0.0000240592,0.0006270541,0.00001753674,0.00007485937,0.000007217327,0.000008163633,0.00006370468],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980227,0.0006796607,0.000006028791,0.0003849454,0.0001048051,0.0006538765,0.00009379475,0.000006320624,0.00004786113],"genre_scores_gemma":[0.9993634,0.0004421811,0.00003452805,0.00006530919,0.000005669006,0.00002350449,0.00003395853,0.000007730082,0.00002374012],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01273627,"threshold_uncertainty_score":0.3038127,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01622354310530569,"score_gpt":0.2781429838210079,"score_spread":0.2619194407157023,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}